H.C. Wainwright Reiterates Buy Rating on VolitionRX (VNRX)

September 10, 2025 7:32 AM UTC Send to a Friend
H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $2.50 price target on VolitionRX (NYSE: VNRX).The analyst commented: "Yesterday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login